RYDER — History
CCN 400007 | 3-year financial timeline | COVID resilience: 77/100
🛡️ Public data only — no PHI permitted on this instance.
$36M
Latest Revenue (FY2022)
+7.5%
Revenue CAGR (3yr)
-20.7%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $31M | $33M | $36M | +6.0% | +7.5% |
| Operating Expenses | $46M | $42M | $43M | +2.2% | -3.0% |
| Operating Margin | -48.3% | -25.2% | -20.7% | +18.0% | +0.0% |
| Net Income | $-15M | $-8M | $-7M | +13.0% | +0.0% |
| Licensed Beds | 165 | 165 | 165 | +0.0% | +0.0% |
| Total Patient Days | 17,203 | 18,586 | 23,206 | +24.9% | +16.1% |
| Medicare Day % | 8% | 5% | 6% | +9.2% | -15.4% |
| Medicaid Day % | 28% | 38% | 30% | -20.2% | +3.0% |
COVID Impact & Recovery
Resilience Score: 77/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +15.6% ($31M → $36M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+7.5%
This Hospital
+7.6%
State Avg
Latest Margin
-20.7%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $38M | -6.9% |
| FY2024 (proj) | $40M | 7.0% |
| FY2025 (proj) | $43M | 20.8% |